| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2981544 | The Journal of Thoracic and Cardiovascular Surgery | 2012 | 10 Pages |
Abstract
Targeting the CXCL12/CXCR4 axis with BKT140 attenuated NSCLC cells tumor growth and augmented the effects of chemotherapy and radiotherapy. Future research will benefit from delineating the downstream mechanism of BKT140 action and defining BKT140 susceptibility markers.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Duha MSc, Ido D. PhD, Michal PhD, Katia PhD, Wald Hanna, Zippora MSc, Orly PhD, Gideon MD, Uzi MD, Oz M. MD, Amnon PhD, Ori MD, PhD,